Risk arising from the performance and policy changes of OEM customers for medical equipment
First written in FY2020. 2 of 4 entries say "Mitigated", first in FY2021. Latest entry: FY2023.
The whole theme swung hardest in 2017: 4 of 15 companies on the "Worse" side.
11 other companies' latest entry also says "Restated".
- FY2023RestatedAnnual report
「Medical devices, the main pillar of this business, are supplied largely on an OEM basis and may be affected by the performance of OEM customers and changes in their management policies.」
The company reiterates the risk of performance deterioration or management policy changes at OEM customers for medical devices, together with its response through joint development and regular meetings. - FY2022MitigatedAnnual report
「The group works to maintain and strengthen its business relationships with OEM customers through joint development and regular technical and sales liaison meetings.」
The company continues its measures to maintain and strengthen relationships with OEM customers through joint development and regular meetings in response to the risk of changes in their performance and policies. - FY2021MitigatedAnnual report
「The group works to maintain and strengthen its business relationships with OEM customers through joint development and regular technical and sales liaison meetings.」
In response to the risk of OEM customers’ performance and policy changes, the company describes measures to maintain and strengthen relationships through joint development and regular meetings. - FY2020First statedAnnual report
「Medical devices, the main pillar of this business, are supplied largely on an OEM basis and may be affected by the performance of OEM customers and changes in their management policies.」
The company has, for the first time, separately identified as a risk the impact of OEM customers’ performance and changes in their management policies, given that most medical devices are supplied on an OEM basis.